Browsing: Targets

RFK Jr. full interview 21:11• Source: CNN RFK Jr. full interview 21:11 See all topics

Protein has moved beyond sports nutrition to become a mainstream F&B ingredient. While new protein ingredients expand formulation opportunities, manufacturers must meet rising consumer expectations for convenience and taste. 

Between consumers’ diet intentions and confusion about gut health, WK Kellogg Co’s Kashi brand is leveraging its better-for-you breakfast and snacking reputation to create Kashi Gut Health Granola, which the company describes as a “straightforward” granola designed specifically for digestive wellness

A new study from Northwestern Medicine investigators, in collaboration with Biohub, a program of the Chan Zuckerberg Initiative, has identified potential drug targets for treating psoriasis, according to the study published in Nature Communications

Eli LillyLLYfell 0.35% in premarket after reporting positive results from two further Phase 3 trials of retatrutide and confirming it will submit a biologics license application to the FDA in the first quarter of 2027. The drug targets three metabolic hormones, GLP-1, GIP and glucagon, against two for Lilly’s current Zepbound and one for Novo…

China aims to effectively curb the rising incidence of major chronic diseases and raise the average life expectancy to 80 years by 2030, up from 79.25 years in 2025, according to a national health plan for the 15th Five-Year Plan period (2026-30)

Samsung Biologics has offered to buy PolyPeptide for CHF 1.46 billion ($1.8 billion), marking a move into peptide manufacturing

A coalition focused on healthcare affordability is reiterating calls to freeze or lower health insurance costs and will take that message to Harrisburg later this month

LAS VEGAS (KSNV) —Federal prosecutors say healthcare fraud is becoming one of the fastest-growing crimes in Nevada, prompting the U.S. Department of Justice to launch a new regional task force focused on protecting patients and taxpayers

|| An official from GC Green Cross Wellbeing introduces the Ribonne and polydeoxyribonucleotide (PDRN) product lineup at the “ASLS TOKYO 2026” conference held in Tokyo, Japan, on the 28th of last month. Photo courtesy of GC Green Cross Wellbeing